Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn’s disease-Reference-Cited by-同舟云学术

Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn’s disease

Published:2017-11-28 Issue:44 Volume:23 Page:7888-7898
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Sun Chen-Ming,Wu Jie,Zhang Heng,Shi Gan,Chen Zhi-Tao

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference41 articles.

1. Candidate Serum Markers in Early Crohn’s Disease: Predictors of Disease Course

2. Eldelumab [anti-interferon-γ-inducible protein-10 antibody] Induction Therapy for Active Crohn’s Disease: a Randomised, Double-blind, Placebo-controlled Phase IIa Study

3. Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study

4. Progression of inflammatory bowel disease in China

5. Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies;Experimental Cell Research;2024-10

2. Updates on the role of epigenetics in familial mediterranean fever (FMF);Orphanet Journal of Rare Diseases;2024-02-26

3. Circ_0001666 upregulation promotes intestinal epithelial cell fibrosis in pediatric Crohn's disease via the SRSF1/BMP7 axis;The Kaohsiung Journal of Medical Sciences;2023-08-02

4. Circulating Small RNA Profiling of Patients with Alveolar and Cystic Echinococcosis;Biology;2023-05-13

5. Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy;European Journal of Medical Research;2023-01-27